Vulnerability Details : CVE-2018-14787

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Published 2018-08-22 18:29:00
Updated 2022-04-22 19:23:39
Source ICS-CERT
View at NVD,   CVE.org
Vulnerability category: Execute code

Exploit prediction scoring system (EPSS) score for CVE-2018-14787

EPSS FAQ
0.04%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 8 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2018-14787

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
4.6
 MEDIUM AV:L/AC:L/Au:N/C:P/I:P/A:P
3.9
6.4
 NIST
7.8
 HIGH CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
1.8
5.9
 NIST

CWE ids for CVE-2018-14787

  • The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
    Assigned by:
    • ics-cert@hq.dhs.gov (Secondary)
    • nvd@nist.gov (Primary)

References for CVE-2018-14787

Products affected by CVE-2018-14787

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!
Accept Close